0 13

Cited 0 times in

Ethyl pyruvate ameliorates inflammatory arthritis in mice

Authors
 Seung Min Jung  ;  Jaeseon Lee  ;  Seung Ye Baek  ;  Juhyun Lee  ;  Se Gwang Jang  ;  Seung-Min Hong  ;  Jin-Sil Park  ;  Mi-La Cho  ;  Sung-Hwan Park  ;  Seung-Ki Kwok 
Citation
 International Immunopharmacology, Vol.52 : 333-341, 2017 
Journal Title
 International Immunopharmacology 
ISSN
 1567-5769 
Issue Date
2017
Keywords
Ethyl pyruvate ; HMGB1 ; Pyruvate ; Rheumatoid arthritis ; T helper 17 cells
Abstract
OBJECTIVES: Ethyl pyruvate (EP) is the ethyl ester of pyruvate and has antioxidative and anti-inflammatory effects. This study aimed to evaluate the therapeutic effect of EP in inflammatory arthritis and to identify the underlying mechanisms. METHODS: Mice with collagen-induced arthritis (CIA) were treated with the vehicle control or EP at 20mg/kg, and clinical and histological analyses were performed on the animals. The differentiation of murine CD4+ T cells into T helper 17 (Th17) cells in the presence of EP was investigated in vitro. The effects of EP on osteoclastogenesis were determined by staining for tartrate-resistant acid phosphatase, and measuring the mRNA levels of osteoclastogenesis-related genes. The expression of high-mobility group box 1 (HMGB1) was evaluated after EP therapy using immunohistochemical staining and Western blotting. RESULTS: EP significantly improved the clinical and histological features of arthritis in CIA mice. EP suppressed the differentiation of CD4+ T cells into Th17 cells, and inhibited the expression of RORγt. The generation of osteoclasts and osteoclastogenic markers from murine and human monocytes was significantly reduced in the presence of EP. The expression of HMGB1 in the synovium was significantly lower in CIA mice treated with EP, compared to control CIA mice. During osteoclastogenesis, HMGB1 release from monocytes was inhibited in the presence of EP. CONCLUSIONS: EP attenuated synovial inflammation and bone destruction in the experimental arthritis model through suppression of IL-17 and HMGB-1. The data suggests that EP could be a novel therapeutic agent for the treatment of inflammatory arthritis, such as rheumatoid arthritis.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/161685
DOI
10.1016/j.intimp.2017.09.027
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
Yonsei Authors
정승민(Jung, Seung Min )
사서에게 알리기
  feedback
Full Text
https://www.sciencedirect.com/science/article/pii/S156757691730365X
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse